Taiwan Government Supports Creating Solid Clinical Trial Environment - DIA Exclusive 

BOSTON - Taiwan's Bureau of Pharmaceutical Affairs and Center for Drug Evaluation brought a large delegation to promote the country's clinical trial environment at the Drug Information Association's 44th annual meeting held this year in Boston. BPA Deputy-Director General Li-Ling Liu and CDE Executive Director Herng-Der Chern, spoke with PharmAsia News on the sidelines of the conference about the country's efforts to make Taiwan an attractive location for clinical development